Vumerity (diroximel fumarate) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis.
Could a new immunotherapy treatment for EBV treat MS?
Just a reminder that the Centre will be closed on Monday 2 May as this is a Bank Holiday. We will reopen as normal on Tuesday.
MS Society launch their 'Extra Costs of MS' survey
Could you join our team for the RideLondon 100 mile bike ride on 29 May?
A big welcome to Kim!
A couple of stories from this week's MS Awareness Week
Do you sometimes struggle to find the right word?
Our popular collections are back!
In MS Awareness Week, find out about the science behind MS and some of the latest developments in MS research. It will take place on Thursday 21 April 2022 at 7pm
